CELG Stock News 147.38 05/19/2014 15:34:51 Celgene Corp (CEL

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 147.38 $CELG

Midday Glance: Biotechnology companies
AP - Mon May 19, 12:21PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:

Early Glance: Biotechnology companies
AP - Mon May 19, 9:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
GlobeNewswire - Mon May 19, 7:05AM CDT
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ), and CRD Analytics today announced the results of the semi-annual re-ranking of the NASDAQ OMX CRD Global Sustainability Index (Nasdaq:QCRD), which will become effective prior to market open on Monday, May 19, 2014.

3 Companies Frightened by This Medicare Study
Todd Campbell, The Motley Fool - Motley Fool - Sun May 18, 6:05AM CDT
Everyone knows that medical costs are soaring, and that those costs present one of the biggest financial challenges to the next generation. But far fewer know that one of the biggest drug buyers, the Centers for Medicare and Medicaid Services, or...

Final Glance: Biotechnology companies
AP - Fri May 16, 5:05PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

After Yesterday's Decline of 1.03%, Celgene Offers Investors Better Value
Comtex SmarTrend(R) - Fri May 16, 3:52PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $145.30 to a high of $150.20. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $148.00 on volume of 2.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for Celgene to Potentially Rebound After Falling 1.03% Yesterday
Comtex SmarTrend(R) - Fri May 16, 3:51PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $145.30 to a high of $150.20. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $148.00 on volume of 2.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Upcoming Conferences, Stock Price Movements and Support to Humanitarian Programs - Analyst Notes on Celgene, Biogen Idec, Incyte, Jazz Pharmaceuticals and Medivation
PR Newswire - Fri May 16, 6:00AM CDT
Today, Analysts Review released its analysts' notes regarding Celgene Corporation (NASDAQ: CELG), Biogen Idec Inc. (NASDAQ: BIIB), Incyte Corporation (NASDAQ: INCY), Jazz Pharmaceuticals plc (NASDAQ: JAZZ) and Medivation Inc. (NASDAQ: MDVN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2548-100free.

Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2014
Business Wire - Wed May 14, 4:19PM CDT
Celgene International Sarl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced more than 65 abstracts reporting on investigational studies in blood and solid tumor cancers will be presented during the 50th American Society of Clinical Oncology meeting in Chicago, Ill. from May 30 to June 3, 2014.

Critical Alerts For DirecTV, JPMorgan, First Solar, Celgene, and Baidu.com Released By InvestorsObserver
PR Newswire - Wed May 14, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for DTV, JPM, FSLR, CELG, and BIDU.

Clinical Trial Results, Acquisitions, Healthcare Partnership, and Pricing of Senior Notes - Analyst Notes on Merck, JNJ, Chelsea, Unitedhealth and Celgene
PR Newswire - Tue May 13, 6:20AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co. Inc. (NYSE: MRK), Johnson & Johnson (NYSE: JNJ), Chelsea Therapeutics International Ltd. (NASDAQ: CHTP), Unitedhealth Group, Inc. (NYSE: UNH) and Celgene Corporation (NASDAQ: CELG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2377-100free.

Celgene Rises 2.63% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon May 12, 4:00PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $145.70 to a high of $151.00. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $147.99 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 151

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 95

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 9

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 280

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 192

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 132

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 150

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading

Top 5 Most Recently Viewed Articles

CrossCountry Mortgage Expands Asset Management with Growth

Updated Category News Views 348

Expansion of CrossCountry Capital CrossCountry Capital, part of CrossCountry Mortgage, is making headlines with its impressive growth. Recently, they announced that they have received over $1 billion in equity capital commitments, paving the way for more than $20 billion in new loan investments. This development reflects the rapid evolution of their asset management...

Continue Reading
PBIRx Strengthens Leadership to Elevate Client Services

Updated Category News Views 65

PBIRx, Inc. made waves in the pharmacy benefit consulting world back in 2024 by promoting Stacy Mathews to Director of Account Management. You know what that means? Major shifts on the horizon for this player trying to navigate an ever-changing healthcare landscape. Stacy Mathews: The New Force Behind PBIRx Stacy’s rise within PBIRx wasn’t just a lucky break; she came...

Continue Reading
NatGold Digital Crosses Into European Crypto Territory

Updated Category News Views 93

Amidst the ever-turning gears of digital finance, NatGold Digital has staked its claim, looking to make waves across the Atlantic. As per the word from Miami, they're bringing their fancy digital mining show to the biggest digital asset parade grounds: Europe. It's not just a dip of the toe, either—they're gunning for the whole European Economic Area. A bit ambitious,...

Continue Reading
Cotti's Journey to 10,000 Stores: Challenges and Strategies Ahead

Updated Category News Views 581

Cotti's Journey to Milestone Achievement Cotti Coffee has recently celebrated a remarkable achievement, reaching the milestone of 10,000 stores in a span of just two years. This expansion has been fueled by a fierce price war against its rival, Luckin Coffee. While this rapid growth is impressive, questions arise regarding the sustainability of Cotti's low-price strategy...

Continue Reading
CIRO Schedules Hearing for Allegations Against Abid Hossain

Updated Category News Views 145

Overview of the Disciplinary Hearing A hearing has been set before a panel of the Canadian Investment Regulatory Organization (CIRO) regarding allegations against Abid Hossain. This case arises under the Mutual Fund Dealer Rules, highlighting the importance of integrity in financial services. Public Access to the Hearing The upcoming disciplinary hearing will be open to...

Continue Reading